Category: Alternative Medicine

  • Stroke management: Expert suggests alternative therapies

    Stroke management: Expert suggests alternative therapies

    Stroke is one of India’s major triggers of demise, with 1.8 million people today struggling a stroke every single calendar year, states Dr G Prakash, Deputy CMO, Jindal Naturecure Institute. He provides that submit-stroke, a person may perhaps working experience “cognitive deficits, motor deficits, exhaustion, and slumber disorders”. “While regular clinical care such as medicine and remedy is generally prescribed to stroke survivors, analysis has shown that CAM (Complementary and Alternative Medicine) therapies can substantially enhance the good quality of daily life and functionality throughout the restoration section from a stroke. While present day drugs has an essential aspect in stroke recovery, applying distinct naturopathic methods, the method of restoration from stroke can be improved and sped up,” he proceeds.

    Stroke can come about at any age to any human being. Nonetheless, the prospects of a stroke significantly increase if a human being has both of the pursuing chance components:

    Heart condition
    Large blood tension
    Diabetic issues
    Cigarette smoking
    Higher blood cholesterol/Triglycerides
    Abnormal alcohol use
    Obesity
    Lack of training
    Genetic or heredity aspects

    Alternate therapies for efficient recovery from stroke

    “Post-stroke, patients may well opt for CAM therapies to get reduction from several physical signs or symptoms like immobility or agony as effectively as reduction from psychological disorders these types of as despair, anxiousness, or grief. In this article we appear at a variety of substitute therapies for stroke survivors for a greater final result in recovery,” the professional says.

    Yoga
    Stroke survivors normally encounter concerns with coordination and balance, and yoga proves effective to strengthen all those impairments. “According to a study by the American Journal of Recreation Treatment, yoga can boost stability, make improvements to variety of movement and psychological regulation, as perfectly as carry optimistic changes in participation and action in people today with long-term stroke. The stretching, strengthening, stability, and system awareness exercise routines included in yoga can make a myriad of rewards for stroke individuals,” he shares.

    mental health Yoga and meditation can be exceptionally helpful. (Resource: Getty Images/Thinkstock)

    Acupuncture
    The Chinese complementary medicine – acupuncture – consists of skin penetration with great needles at specified factors. “Research and scientific tests have shown that acupuncture increases challenges with spasticity, suffering, physical capabilities, cognitive features, and high quality of lifestyle if administered immediately after a stroke. Apart from facilitating restoration of purpose, acupuncture assists in the improvement of the anxious system functions, which is remarkably desirable in stroke people. The remedy is effective by stimulating the nervous technique, which releases chemical compounds into the mind, spinal cord, and muscular tissues. This stimulates the purely natural healing potential of the human body and encourages physical and psychological perfectly-staying,” he points out.

    Massage treatment
    Therapeutic massage therapy can manipulate the tissues in the physique to boost in general nicely-becoming and well being. The Journal of Chinese Integrative Drugs released a research in 2012 “revealing that organic solutions and Thai massage can boost temper, everyday perform, suffering, and sleeping designs in stroke survivors. Scientists have also pointed out that specified massages can help in improving upon wonderful motor techniques in stroke patients,” he claims.

    Natural supplements
    There are a selection of organic nutritional supplements out there that enhances blood circulation and stops an additional stroke. Some of the well known herbal nutritional supplements, in accordance to the qualified, are:
    Asian Ginseng – This Chinese natural health supplement enhances memory.
    Ashwagandha – Ashwagandha or Indian Ginseng is loaded with antioxidant houses that may possibly take care of and avoid stroke.
    Gotu Kola – Gotu Kola or Centellaasiatica is a staple component in classic Chinese medicine. This herb which is generally identified in the wetlands of Asia, boosts cognitive purpose and also acts as an antidepressant.
    Bilberry – This nutrient-loaded fruit aids to lower blood sugar and cholesterol degrees.
    Turmeric – Turmeric consists of a compound, Curcumin which not only assists in preventing blockages in the arteries but also reduces fatty deposits recognized as plaques in them.

    Hydrotherapy
    Hydrotherapy, also acknowledged as aquatic treatment, is a treatment that helps make use of drinking water to treat diverse sorts of clinical problems, together with stroke. “Hydrotherapy offers a risk-free surroundings for stroke sufferers to maximize their mobility and toughness, decrease suffering and increase general cardiovascular overall health. When aqua remedy is put together with distinct exercise routines, it serves as an superb way to regain physical expertise devoid of putting way too significantly tension on the physique,” hesays.

    Fasting treatment
    Naturopathy considers fasting remedy as one particular of the most efficient methods to get rid of toxins from the overall body. Reports have shown that fasting lessens homocysteine, IL6 and C-reactive protein in the body that may kind atherosclerotic plaques, which raises the prospects of stroke. Other than cutting down the risk of stroke, fasting treatment also fosters the growth of neurons and new neuronal connections in the course of restoration from stroke. Fasting therapy more enhances the body’s inflammatory response technique and lowers the possibility of tissue problems immediately after stroke.

    For stroke restoration and avoidance, CAM therapies occur with numerous gains. “Other than important life style modifications, choice solutions like acupuncture and nutritional supplements can make a substantial difference in the end result of stroke recovery. Even though these therapies are not meant to swap traditional, fashionable medical procedure protocols in stroke administration, they have the probable to assist attain quicker recovery and far better prevention by their pure methods,” he says.

    The higher than short article is for information and facts uses only and is not intended to be a substitute for expert medical advice. Generally look for the direction of your health care provider or other qualified well being specialist for any questions you might have regarding your well being or a clinical condition.
    📣 For extra lifestyle news, follow us on Instagram | Twitter | Fb and don’t overlook out on the most up-to-date updates!

  • Older women, younger men may be at risk

    Older women, younger men may be at risk

    blood pressure monitor seen from up closeShare on Pinterest
    Older women and younger men in the U.S. may be at risk of uncontrolled hypertension, according to a new study. Bowery Image Group Inc./Stocksy
    • Controlling blood pressure is a major challenge for close to half of all adults in the United States.
    • Researchers say that older women and younger men are more likely to have uncontrolled hypertension, even with blood pressure-lowering medications.
    • Health experts say that lifestyle choices and a low tolerance for certain medications can make it hard to manage hypertension.

    Hypertension, or high blood pressure, elevates people’s risk of several illnesses, including cardiovascular and kidney disease, stroke, and complications from COVID-19.

    More than 92 million adults in the U.S. do not have their blood pressure under control.

    Until now, studies have barely explored how uncontrolled hypertension affects men and women at different ages.

    Aayush Visaria, M.D., M.P.H., who is a postdoctoral research fellow at Rutgers Institute for Health, Health Care Policy and Aging Research in New Brunswick, NJ, led a study examining this issue.

    Dr. Visaria presented the study’s results at the Hypertension Scientific Sessions 2021, which the American Heart Association (AHA) ran.

    Dr. Visaria and his cohorts examined data from the 1999–2018 National Health and Nutrition Examination Surveys.

    These included more than 13,200 adults aged 20 years and older, all of whom had received a diagnosis of hypertension and were on blood pressure-lowering medication.

    The average age in the cohort was 57 years. Women made up 52{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} of the participants, 71{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} of whom were white.

    The researchers separated the participants into 10-year age groups and compared the rates of uncontrolled hypertension between men and women.

    They looked at rates of hypertension control using older and newer definitions of high blood pressure. The 2014 Joint National Commission (JNC) guidelines define high blood pressure as 140/90 millimeters of mercury (mm Hg) or higher, whereas the 2017 AHA/American College of Cardiology (ACC) guidelines define it as 130/80 mm Hg or higher.

    The researchers adjusted their data for comorbidities and metabolic, social, behavioral, and demographic factors.

    The authors noted that 34{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} of the 13,253 participants had uncontrolled hypertension. Women and men aged 50–69 years showed similar odds of having this condition.

    However, the researchers observed these differences among other age groups:

    • Among those aged 20–29, men showed a 59{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} greater chance of uncontrolled hypertension than women.
    • Among those aged 30–39, men had a 70{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} increased risk of uncontrolled hypertension compared with women.
    • Among those aged 40–49, men were 47{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} more likely to have uncontrolled hypertension than women.
    • Among those aged 70–79, women had a 29{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} greater chance of uncontrolled hypertension compared with men.
    • Among those aged 80 and older, women were 63{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} more likely to have uncontrolled hypertension than men.

    These results are based on the AHA/ACC guideline definition of hypertension. However, using the JNC definition produced similar findings.

    Derek M. Griffith, Ph.D., is the founding co-director of the Racial Justice Institute, founder and director of the Center for Men’s Health Equity, and professor of health systems administration and oncology at Georgetown University in Washington, D.C.

    In an interview with Medical News Today, Dr. Griffith commented:

    “It is great to see the American Heart Association begin to look at these issues by gender. We have long known that men under 50 have particularly poor health profiles, despite middle-age being portrayed as the prime of life. From age 35 and up, heart disease is one of the top two leading causes of death for men, and much of heart disease mortality is due to uncontrolled hypertension.”

    Dr. Griffith cited a 2018 study suggesting that men aged 45–64 years had a higher risk of stroke than women in both Black and white populations.

    He believes that young and middle-aged men struggle with heart health “because of the multiple role demands and financial pressures that cluster in middle-age.”

    Dr. Griffith further explained:

    “The current generation of young adults have tended to delay pursuing key adult roles and responsibilities, [such as] marriage, homeownership, and beginning careers. [They have] faced considerable student loan debt, stagnant wages, increased social isolation, and sedentary behavior associated with technology use — [for example,] social media, video games, [and] binge watching shows and movies. These factors are sources of stress that may raise blood pressure and stimulate unhealthy eating, sugar sweetened beverage consumption, smoking, alcohol use, and other behaviors […]. These stress-coping behaviors can lead to high blood pressure.”

    In middle age, he added, physical decline often results from lifestyle choices and experiences up to that point.

    Jennifer Wong, M.D., FACC, is a cardiologist and medical director of noninvasive cardiology at MemorialCare Heart and Vascular Institute at Orange Coast Medical Center in Fountain Valley, CA.

    In an interview with MNT, Dr. Wong remarked that the findings matched her own anecdotal observations. She mentioned several factors contributing to higher incidences of uncontrolled hypertension in young men:

    “I think for younger patients, it could be an element of noncompliance: not going to doctors, not taking medications — […] especially young men.”

    She has seen that hypertension in some of her young male patients is more resistant to medications. Younger individuals “also tend to be more sensitive to medications.”

    Moreover, Dr. Wong said, young patients often do not tolerate beta-blockers, a common blood pressure-lowering medication.

    According to Dr. Visaria and his co-authors, “[…] women tend to have an accelerated increase in blood pressure and cardiovascular disease risk after menopause.”

    For Dr. Wong, treating some older women with uncontrolled hypertension presents a challenge.

    She has observed: “[O]lder women tend not to tolerate lower blood pressures, so [it’s] difficult to treat the high blood pressures without running into lower blood pressure where they feel underperfused.”

    Dr. Wong expressed concern that society underestimates the prevalence and severity of cardiovascular disease in women.

    Although men are more likely than women to develop heart disease, this illness “is still the number one killer in women, more than breast cancer.”

    The study did have some limitations. For instance, the researchers’ health data provided only one blood pressure reading at one time point for each participant. This single reading could not accurately quantify blood pressure, which normally fluctuates throughout the day.

    Dr. Visaria also expressed the need for further research to discover the mechanisms behind these differences in uncontrolled hypertension.

    He suggests: “In order to really determine whether uncontrolled hypertension rates are changing in women vs. men across age, a prospective study where blood pressure measurements are tracked over time in women and men with hypertension is ideal.”

  • Do Herbs, Diet and Other Approaches Affect Cancer Outcomes?

    Do Herbs, Diet and Other Approaches Affect Cancer Outcomes?

    Surviving most cancers is about more than just finding surgical procedure, chemotherapy or other remedies, says one particular pro. It also involves giving your body the delicate awareness to wellness that it requires – like taking care of anxiety, seeking social assist, sustaining a healthier diet plan and more.

    It’s critical for most cancers survivors to deal with their good quality of existence, which they can do by employing integrative medicine. This knowledge can assist them get their body via remedy with fewer signs and keep well adequate to enable the therapies do the job proficiently.

    “It’s the concept of taking most effective common of treatment, and combining it with almost everything else that’s out there, for wherever you will find evidence of protection and effectiveness… But it is a principle that thinks of all of you, not just the part of you that we see when you’re in an operating room or in an business office or on a chemo unit,” claimed Dr. Diljeet K. Singh, a gynecologic oncologist with the Mid-Atlantic Permanente Medical Team in Washington, DC, in a presentation at the 12th Once-a-year Joining Forces In opposition to Hereditary Cancer Meeting.

    The integrative oncology ways incorporate nutritional interventions, medicine that focuses on the thoughts, system or electrical power and methods of natural medication or other approaches these as acupuncture.

    Nutritional Techniques to Most cancers Wellness

    Even though trials are nonetheless ongoing to evaluate ketogenic meal plans, early facts has proven there might be some benefit to lessening specific forms of tumor advancement, Singh reported.

    The ketogenic food plan operates by cutting out lower-top quality carbohydrates and sugar though incorporating additional body fat and protein in the diet, as a result forcing the physique to engage in ketosis – or the frequent burning of extra fat.

    “As men and women commence imagining about ketogenic weight loss plans for the full time they are on chemotherapy or even to check out to drop weight, lengthy-time period cutting out entire subgroups is challenging, in addition to the fact that there are some issues on the ketogenic food plan that we know enhance cancer hazard from other diet programs,” Singh mentioned.

    Nonetheless, she added, there are also things removed by the ketogenic diet regime that boost most cancers chance – so it is continue to early to know what the genuine gain is, except if you have a neural or brain tumor and a wellness treatment provider with working experience working with ketogenic eating plans.

    Conversely, a method that has experienced some results worth shelling out interest to, Singh explained, is fasting.

    Fasting can be divided into various categories: drinking water fasting, throughout which an particular person only drinks water or h2o-dependent beverages dry fasting, which indicates not taking in anything and restrictive fasting, which is when only specified meals are minimal.

    “The study is not in which we want it nevertheless, but there is proof that there are sure foods that physiologically mimic fasting,” Singh said. “And finally, I imagine these may well be the most meaningful or valuable strategies.

    The duration of fasting is at the time all over again divided into classes: steady for a described period (12-24 hours for up to a number of days) intermittent fasting (consuming at specific instances through the day) and total working day fasting for a person or two days each week.

    New information suggests that it may possibly improve most cancers results, Singh spelled out. Animal studies have demonstrated diminished toxicity and improved performance of chemotherapy with fasting. It is effective by depriving the regular cells of nutrients, which safeguards them from chemotherapy since they are not doing their standard growth functions, though the cancer cells expend electricity and are much more vulnerable to remaining attacked.

    The in-human studies are continue to constrained and ongoing, though, and it’s essential to continue to keep in head no matter whether the diet plan is correct for selected people. This might be individuals who have ingesting issues, diabetic issues, low system mass index or have not too long ago dropped excess weight.

    “But finally, I believe however the spot where by we have the most information is the Mediterranean food plan,” Singh emphasized. “And what I contemplate the a person-action improvement for it, the anti-inflammatory eating plan, which is primarily the Mediterranean diet program, including in some vital ideas from common Chinese medication and Ayurvedic drugs.”

    This diet program is centered on fruits and vegetables, whole grains, balanced fat, fish and seafood as protein – but also entire soy, cooked Asian mushrooms, healthful herbs and spices.

    “The purple wine aspect is a little bit challenging, since there is evidence that for females to have extra than two eyeglasses of crimson wine a week may perhaps maximize the danger of breast cancer,” Singh said. “So I would say for ladies, sadly, the better choice is to take in grapes, and then points like basic darkish chocolate, which has actually terrific antioxidants in it, as perfectly as magnesium and other advantageous parts.”

    Comprehending the Positive aspects of Herbs and Nutritional supplements

    A lot of individuals are fascinated in whether or not herbs and dietary supplements can present well being added benefits that will either stop or work in opposition to cancer. Having said that, the idea that they might be improved than a capsule offered to you by your medical professional is not fully genuine, claimed Singh.

    “Certainly, herbs and other nutritional supplements when we do them in pharmacologic doses, like not an quantity that you could consume in a healthful way, they really can in pretty numerous means act like additional traditionally recommended prescriptions for even about-the-counter medicines,” she mentioned. “But there is a real rationale to be fascinated by herbs and health supplements, and that’s simply because they have the potential to improve high-quality of wellbeing and improve most cancers results.”

    Reliable epidemiologic details showed that individuals who ate extra orange and yellow fruits and greens experienced reduced cancer costs. Quite a few questioned regardless of whether this could be attributed to beta-carotene. In medical trials, scientists examined no matter whether smokers who been given beta-carotene and retinyl palmitate would have a decreased most cancers danger. Nevertheless, it was uncovered that this elevated their danger of lung most cancers.

    On the other hand, Singh explained, they analyzed to see if nutritional vitamins A or E experienced any result. It was located that vitamin A also greater cancer chance, whilst vitamin E experienced no influence.

    “How could having nutritional vitamins boost your most cancers hazard? … So there could possibly be a entire bunch of factors. A person was that determination was manufactured to use a artificial sort of vitamin A, which is not basically uncovered in fruits and veggies,” Singh spelled out. “We know what vitamin A, what (its) career is, is to aid just one mobile differentiate on into one more cell – so stem cells form of turning into an genuine pores and skin cell. And so contemplating about that, very well, maybe if we put in an activated vitamin A, and there is certainly a precancerous mobile sitting about, perhaps that’s likely to be much more likely with the addition of vitamin A, to go on to develop into a lung cancer.”

    As a result, the analyze may not have been completed in the proper populace, as people who smoke previously have precancers in put that then were stimulated into turning into most cancers when they took vitamin A.

    “I contact this – and heaps of smart persons call this – the dilemma of reductionism, right? You cannot put a whole apple into a capsule.”

    There are added benefits to consuming whole foodstuff in their initial sort, Singh urged. For instance, drinking orange juice might not aid as substantially as feeding on an orange, since you are having out the fiber, introducing sugar and slowing down the body’s absorption. This is why it’s difficult to review nutritional results, due to the fact conducting investigate on integrative approaches means you have to analyze someone’s complete way of living and complete food plan.

    When pondering about herbs and supplements, Singh described, the ideal method is to do the job with an qualified who has an being familiar with of their consequences on the human body. It’s tricky, mainly because the Foodstuff and Drug Administration (Food and drug administration) does not examine the safety of herbs, so they are not as effectively recognized. But your pharmacist and health and fitness treatment supplier can assistance you to realize whether certain herbs and supplements may perhaps interact with your most cancers solutions. Furthermore, claimed instances of troubles are exceedingly uncommon.

    Acupuncture Is Not a Legitimate Choice

    While acupuncture has been all-around for hundreds of years, Singh reported, it is not an substitute to cancer therapy. It has been utilized to handle indications like nausea and vomiting, tiredness, discomfort, very hot flashes, peripheral neuropathy and dry mouth of radiation.

    Having said that, it’s not a substitute for cancer medication.

    A Glimpse into Stress and Most cancers

    With a fantastic offer of proof exhibiting tension can each boost the threat of cancer and worsen the impacts of most cancers as soon as you have it, Singh emphasized that it is critical to do the job on methods to beat it.

    Though psychological stressors these kinds of as melancholy, stress and anxiety and isolation can worsen a patient’s affliction, some will urge that they truly feel good “emotionally.” However, it is essential to also look at the bodily stress of multi-tasking, driving and making an attempt to continue each day everyday living.

    “There’s all varieties of points that turn on our stressed anxious method, flip on our adrenaline cortisol pathway,” Singh said. “…and sadly, that caveman only responds with this adrenaline, cortisol inflammatory pathways. And so turning off that pathway to put our human body into a therapeutic point out, the place within inflammatory mediators come into engage in, is important.”

    There are many various strategies to do this – patients can do respiration exercises, meditate, use inventive retailers, and so on. “But also, great nourishment, regular actual physical activity, controlling stress – all the variants of it, actual physical and emotional – social assistance, acquiring adequate slumber,” Singh concluded.

    For more news on most cancers updates, study and training, really do not fail to remember to subscribe to CURE®’s newsletters here.

  • 1.

    Nelson HD. Menopause. Lancet. 2008;371(9614):760–70.

    PubMed 
    Article 
    PubMed Central 

    Google Scholar
     

  • 2.

    Natari RB, Clavarino AM, McGuire TM, Dingle KD, Hollingworth SA. The bidirectional relationship between vasomotor symptoms and depression across the menopausal transition: a systematic review of longitudinal studies. Menopause. 2018;25(1):109–20.

    PubMed 
    Article 
    PubMed Central 

    Google Scholar
     

  • 3.

    Schbley BH. Socioeconomic factors in menopausal women’s use of hormone replacement therapy. J Women Aging. 2009;21(2):99–110.

    PubMed 
    Article 
    PubMed Central 

    Google Scholar
     

  • 4.

    Whiteley J, DiBonaventura M, Wagner JS, Alvir J, Shah S. The impact of menopausal symptoms on quality of life, productivity, and economic outcomes. J Womens Health. 2013;22(11):983–90.

    Article 

    Google Scholar
     

  • 5.

    Writing Group for the Women’s Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women’s Health Initiative randomized controlled trial. JAMA. 2002;288(3):321–33.

    Article 

    Google Scholar
     

  • 6.

    Committee TWHIS. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women’s health initiative randomized controlled trial. JAMA. 2004;291(14):1701–12.

    Article 

    Google Scholar
     

  • 7.

    Nabulsi AA, Folsom AR, White A, Patsch W, Heiss G, Wu KK, Szklo M. Association of hormone-replacement therapy with various cardiovascular risk factors in postmenopausal women. N Engl J Med. 1993;328(15):1069–75.

    CAS 
    PubMed 
    Article 
    PubMed Central 

    Google Scholar
     

  • 8.

    Stoppe G, Dören M. Critical appraisal of effects of estrogen replacement therapy on symptoms of depressed mood. Arch Women Ment Health. 2002;5(2):39–47.

    CAS 
    Article 

    Google Scholar
     

  • 9.

    Brown S. Shock, terror and controversy: how the media reacted to the Women’s health initiative. Climacteric. 2012;15(3):275–80.

    CAS 
    PubMed 
    Article 
    PubMed Central 

    Google Scholar
     

  • 10.

    Lawton B, Rose S, McLeod D, Dowell A. Changes in use of hormone replacement therapy after the report from the Women’s Health Initiative: cross sectional survey of users. BMJ. 2003;327(7419):845.

    PubMed 
    PubMed Central 
    Article 

    Google Scholar
     

  • 11.

    Rossouw JE, Prentice RL, Manson JE, Wu L, Barad D, Barnabei VM, Ko M, LaCroix AZ, Margolis KL, Stefanick ML. Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause. JAMA. 2007;297(13):1465–77.

    CAS 
    PubMed 
    Article 
    PubMed Central 

    Google Scholar
     

  • 12.

    de Villiers TJ, Hall JE, Pinkerton JV, Cerdas Perez S, Rees M, Yang C, Pierroz DD. Revised global consensus statement on menopausal hormone therapy. Climacteric. 2016;19(4):313–5.

    PubMed 
    Article 
    PubMed Central 

    Google Scholar
     

  • 13.

    Wysowski DK, Governale LA. Use of menopausal hormones in the United States, 1992 through June, 2003. Pharmacoepidemiol Drug Saf. 2005;14(3):171–6.

    PubMed 
    Article 
    PubMed Central 

    Google Scholar
     

  • 14.

    Sarrel PM, Njike VY, Vinante V, Katz DL. The mortality toll of estrogen avoidance: an analysis of excess deaths among hysterectomized women aged 50 to 59 years. Am J Public Health. 2013;103(9):1583–8.

    PubMed 
    PubMed Central 
    Article 

    Google Scholar
     

  • 15.

    LaCroix AZ, Chlebowski RT, Manson JE, Aragaki AK, Johnson KC, Martin L, Margolis KL, Stefanick ML, Brzyski R, Curb JD, et al. Health outcomes after stopping conjugated equine estrogens among postmenopausal women with prior hysterectomy: a randomized controlled trial. JAMA. 2011;305(13):1305–14.

    CAS 
    PubMed 
    PubMed Central 
    Article 

    Google Scholar
     

  • 16.

    Bahri N, Pourali L, Esmaeeli H. Application of various menopausal symptoms treatment options and its related factors, Gonabad- 2016. Iran J Obstet Gynecol Infert. 2016;19(26):1–8.


    Google Scholar
     

  • 17.

    Drewe J, Bucher KA, Zahner C. A systematic review of non-hormonal treatments of vasomotor symptoms in climacteric and cancer patients. Springerplus. 2015;4(1):65.

    PubMed 
    PubMed Central 
    Article 
    CAS 

    Google Scholar
     

  • 18.

    Goldstein KM, Coeytaux RR, Williams JW Jr, Shepherd-Banigan M, Goode AP, McDuffie JR, Befus D, Adam S, Masilamani V, Van Noord MG. Non-pharmacologic treatments for menopause-associated vasomotor symptoms. Washington DC: DVA Health Services Research and Development Service; 2016.


    Google Scholar
     

  • 19.

    Carpenter JS, Byrne MM, Studts JL. Factors related to menopausal symptom management decisions. Maturitas. 2011;70(1):10–5.

    PubMed 
    Article 
    PubMed Central 

    Google Scholar
     

  • 20.

    Siyam T, Carbon J, Ross S, Yuksel N. Determinants of hormone therapy uptake and decision-making after bilateral oophorectomy (BO): a narrative review. Maturitas. 2019;120:68–76.

    PubMed 
    Article 
    PubMed Central 

    Google Scholar
     

  • 21.

    Hyde A, Nee J, Drennan J, Butler M, Howlett E. Hormone therapy and the medical encounter: a qualitative analysis of women’s experiences. Menopause. 2010;17(2):344–50.

    PubMed 
    Article 
    PubMed Central 

    Google Scholar
     

  • 22.

    Manson JE, Aragaki AK, Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Chlebowski RT, Howard BV, Thomson CA, Margolis KL, et al. Menopausal hormone therapy and long-term all-cause and cause-specific mortality: the women’s health initiative randomized trials. JAMA. 2017;318(10):927–38.

    PubMed 
    PubMed Central 
    Article 

    Google Scholar
     

  • 23.

    Langer RD, Hodis HN, Lobo RA, Allison MA. Hormone replacement therapy—where are we now? Climacteric. 2021;24(1):3–10.

    CAS 
    PubMed 
    Article 
    PubMed Central 

    Google Scholar
     

  • 24.

    Thompson JJ, Ritenbaugh C, Nichter M. Why women choose compounded bioidentical hormone therapy: lessons from a qualitative study of menopausal decision-making. BMC Womens Health. 2017;17(1):97.

    CAS 
    PubMed 
    PubMed Central 
    Article 

    Google Scholar
     

  • 25.

    Velentzis LS, Banks E, Sitas F, Salagame U, Tan EH, Canfell K. Use of menopausal hormone therapy and bioidentical hormone therapy in Australian women 50 to 69 years of age: results from a national, cross-sectional study. PLoS ONE. 2016;11(3):e0146494.

    PubMed 
    PubMed Central 
    Article 
    CAS 

    Google Scholar
     

  • 26.

    Bahri N, Sajjadi M, Sadeghmoghadam L. The relationship between management strategies for menopausal symptoms and women’s decision making styles during menopausal transition. Prz Menopauzalny. 2019;18(3):174–9.

    PubMed 
    PubMed Central 

    Google Scholar
     

  • 27.

    Theroux R. Women’s decision making during the menopausal transition. J Am Acad Nurse Pract. 2010;22(11):612–21.

    PubMed 
    Article 
    PubMed Central 

    Google Scholar
     

  • 28.

    Zapata AML, Beaudreau SA, O’Hara R, Bereknyei Merrell S, Bruce J, Garrison-Diehn C, Gould CE. Information-seeking about anxiety and perceptions about technology to teach coping skills in older veterans. Clin Gerontol. 2017;41(8):346–56.

    PubMed 
    PubMed Central 

    Google Scholar
     

  • 29.

    Kingsberg SA, Schaffir J, Faught BM, Pinkerton JV, Parish SJ, Iglesia CB, Gudeman J, Krop J, Simon JA. Female sexual health: barriers to optimal outcomes and a roadmap for improved patient-clinician communications. J Women’s Health (2002). 2019;28(4):432–43.

    Article 

    Google Scholar
     

  • 30.

    Henwood F, Wyatt S, Hart A, Smith J. ‘Ignorance is bliss sometimes’: constraints on the emergence of the ‘informed patient’ in the changing landscapes of health information. Sociol Health Illn. 2003;25(6):589–607.

    PubMed 
    Article 
    PubMed Central 

    Google Scholar
     

  • 31.

    Pache DM, Hollingworth SA, van Driel ML, McGuire TM. Does consumer medicines interest reflect medicines use? An Australian observational study comparing medicines call center queries with medicines use. Res Social Adm Pharm. 2019;15(4):440–7.

    PubMed 
    Article 
    PubMed Central 

    Google Scholar
     

  • 32.

    Benchimol EI, Smeeth L, Guttmann A, Harron K, Moher D, Petersen I, Sørensen HT, von Elm E, Langan SM, Committee RW. The REporting of studies conducted using observational routinely-collected health data (RECORD) statement. PLoS Med. 2015;12(10):e1001885.

    PubMed 
    PubMed Central 
    Article 

    Google Scholar
     

  • 33.

    ATC/DDD Index 2017 https://www.whocc.no/atc_ddd_index/

  • 34.

    Commonwealth Department of Health and Aged Care, National Key Centre for Social Applications of Geographical Information Systems: Measuring remoteness: Accessibility/Remoteness Index of Australia (ARIA) revised edition: Commonwealth Department of Health and Aged Care; 2001.

  • 35.

    Australian Bureau of Statistics: Year book Australia 2012. Canberra: Australian Bureau of Statistics; 2012.

  • 36.

    Beasley TM, Schumacker RE. Multiple regression approach to analyzing contingency tables: Post hoc and planned comparison procedures. J Exp Educ. 1995;64(1):79–93.

    Article 

    Google Scholar
     

  • 37.

    Bazeley P. Analysing qualitative data: More than ‘identifying themes.’ Malays J Qual Res. 2009;2(2):6–22.


    Google Scholar
     

  • 38.

    Pines A, Sturdee DW, Birkhäuser MH, Schneider HPG, Gambacciani M, Panay N. IMS updated recommendations on postmenopausal hormone therapy. Climacteric. 2007;10(3):181–94.

    CAS 
    PubMed 
    Article 
    PubMed Central 

    Google Scholar
     

  • 39.

    Hengen KM, Alpers GW. What’s the risk? Fearful Individuals generally overestimate negative outcomes and they dread outcomes of specific events. Front Psychol. 2019;10:1676.

    PubMed 
    PubMed Central 
    Article 

    Google Scholar
     

  • 40.

    Loewenstein GF, Weber EU, Hsee CK, Welch N. Risk as feelings. Psychol Bull. 2001;127(2):267–86.

    CAS 
    PubMed 
    Article 
    PubMed Central 

    Google Scholar
     

  • 41.

    Shapiro M. Media and education of the consumer. Menopause. 2016;23(8):924–7.

    PubMed 
    Article 
    PubMed Central 

    Google Scholar
     

  • 42.

    Natari RB, McGuire TM, Baker PJ, Clavarino AM, Dingle KD, Hollingworth SA. Longitudinal impact of the Women’s health initiative study on hormone therapy use in Australia. Climacteric. 2019;22(5):489–97.

    CAS 
    PubMed 
    Article 
    PubMed Central 

    Google Scholar
     

  • 43.

    Crawford SL, Crandall CJ, Derby CA, El Khoudary SR, Waetjen LE, Fischer M, Joffe H. Menopausal hormone therapy trends before versus after 2002: impact of the Women’s health initiative study results. Menopause. 2018;26(6):588–97.

    PubMed 
    PubMed Central 
    Article 

    Google Scholar
     

  • 44.

    Ettinger B, Wang SM, Leslie RS, Patel BV, Boulware MJ, Mann ME, McBride M. Evolution of postmenopausal hormone therapy between 2002 and 2009. Menopause. 2018;25(11):1306–12.

    PubMed 
    Article 
    PubMed Central 

    Google Scholar
     

  • 45.

    Kloosterboer SM, McGuire T, Deckx L, Moses G, Verheij T, van Driel ML. Self-medication for cough and the common cold: Information needs of consumers. Aust Fam Physician. 2015;44(7):497–501.

    PubMed 
    PubMed Central 

    Google Scholar
     

  • 46.

    Gartoulla P, Davis S, Worsley R, Bell R. Use of complementary and alternative medicines for menopausal symptoms in Australian women aged 40–65 years. Med J Aust. 2015;203(3):146–146.

    PubMed 
    Article 
    PubMed Central 

    Google Scholar
     

  • 47.

    de Villiers TJ, Gass MLS, Haines CJ, Hall JE, Lobo RA, Pierroz DD, Rees M. Global Consensus Statement on menopausal hormone therapy. Maturitas. 2013;74(4):391–2.

    PubMed 
    Article 
    PubMed Central 

    Google Scholar
     

  • 48.

    Huston SA, Jackowski RM, Kirking DM. Women’s trust in and use of information sources in the treatment of menopausal symptoms. Womens Health Issues. 2009;19(2):144–53.

    PubMed 
    Article 
    PubMed Central 

    Google Scholar
     

  • WHO prioritizes access to diabetes and cancer treatments in new Essential Medicines Lists

    WHO prioritizes access to diabetes and cancer treatments in new Essential Medicines Lists

    WHO today posted the new edition of its Model Lists of Crucial Medications and Important Medications for Youngsters, which incorporate new remedies for different cancers, insulin analogues and new oral medicines for diabetes, new medications to guide individuals who want to cease smoking, and new antimicrobials to address serious bacterial and fungal infections.

    The listings intention to handle world-wide well being priorities, pinpointing the medicines that supply the greatest advantages, and which should be available and cost-effective for all. Having said that, substantial prices for each new, patented medications and older medicines, like insulin, carry on to keep some important medicines out of access for numerous patients.

    “Diabetes is on the increase globally, and growing more rapidly in lower- and middle-cash flow international locations,” reported Dr Tedros Adhanom Ghebreyesus, WHO Director-General. “Too numerous folks who want insulin come across money hardship in accessing it or go without it and eliminate their life. Including insulin analogues in the Crucial Medicines Listing, coupled with efforts to make certain very affordable obtain to all insulin items and broaden use of biosimilars, is a critical stage toward guaranteeing everybody who desires this lifestyle-preserving products can access it.”

    Medications for diabetic issues

    Insulin was found as a therapy for diabetic issues 100 a long time back and human insulin has been on WHO’s Record of Critical Medicines due to the fact it was first posted in 1977. Sadly, minimal insulin source and superior prices in various reduced- and middle-income nations are at the moment a important barrier to treatment. For example, in Ghana’s capital, Accra, the total of insulin desired for a month would value a worker the equal of 5.5 days of pay for every month. Insulin generation is concentrated in a modest quantity of manufacturing facilities, and a few makers management most of the world market place, with the absence of opposition resulting in superior costs that are prohibitive for a lot of people and health methods.

    The move to record lengthy-acting insulin analogues (insulin degludec, detemir and glargine) and their biosimilars, along with human insulin, is intended to increase entry to diabetic issues treatment by increasing the preference of therapy. Inclusion in the List usually means that biosimilar insulin analogues can be suitable for WHO’s prequalification programme WHO prequalification can consequence in much more top quality-assured biosimilars coming into the intercontinental market place, creating opposition to convey costs down and offering nations a increased alternative of solutions.

    Very long-acting insulin analogues give some extra medical added benefits for individuals as a result of their extended duration of motion, which assures that blood glucose concentrations can be managed over for a longer period intervals of time without having needing a booster dose. They offer you distinct advantage for individuals who expertise dangerously very low blood glucose degrees with human insulin. The greater versatility in timing and dosing of insulin analogues has been demonstrated to strengthen high quality of everyday living for people living with diabetes. Nevertheless, human insulin remains a staple in the cure of diabetic issues and obtain to this lifestyle-conserving medicine will have to continue on to be supported as a result of much better availability and affordability.

    The listing also involves Sodium-Glucose Co-transporter-2 (SGLT2) inhibitors empagliflozin, canagliflozin and dapagliflozin as second line treatment in grownups with kind 2 diabetes. These orally administered medicines have been proven to provide many rewards, which include a lessen threat of loss of life, kidney failure and cardiovascular gatherings. Since SGLT2 inhibitors are nonetheless patented and substantial-priced, their inclusion in the checklist comes with the recommendation that WHO work with the Medications Patent Pool to advertise access as a result of possible licencing agreements with the patent-holders to enable generic producing and offer in minimal- and center-earnings nations.

    Improving entry to diabetic issues medicines including insulin and SGLT2 inhibitors is just one of the workstreams of the International Diabetic issues Compact, introduced by WHO in April 2021, and a crucial matter under discussion with companies of diabetes medicines and health and fitness systems.

    Most cancers medicines

    Cancers are amongst the major causes of health issues and loss of life around the world, accounting for virtually 10 million deaths in 2020, with seven out of 10 happening in low- and middle-income countries. New breakthroughs have been produced in cancer treatment method in the past many years, these as medicines that target distinct molecular qualities of the tumour, some of which provide a great deal greater outcomes than “traditional” chemotherapy for many styles of cancer. 4 new medications for cancer treatment were extra to the Model Lists:

    • Enzalutamide, as an alternative to abiraterone, for prostate cancer
    • Everolimus, for subependymal large cell astrocytoma (SEGA), a variety of brain tumour in small children
    • Ibrutinib, a qualified drugs for long-term lymphocytic leukaemia and
    • Rasburicase, for tumour lysis syndrome, a critical complication of some most cancers solutions.

    The listing for imatinib was prolonged to contain targeted cure of leukaemia. New childhood cancer indications had been added for 16 medications already shown, including for reduced-grade glioma, the most prevalent form of mind tumour in children.

    A group of antibodies that greatly enhance the immune response to tumour cells, referred to as PD-1 / PD-L1 immune-checkpoint inhibitors, were not suggested for listing for the remedy of a range of lung cancers, in spite of becoming effective, mostly because of their exceedingly higher rate and issues that they are tricky to deal with in reduced-resourced overall health units. Other cancer medicines ended up not advised for listing due to unsure additional medical profit when compared with currently listed medications, large value, and administration issues in minimal-source configurations. These included osimertinib for lung cancer, daratumumab for many myeloma, and 3 forms of therapy (CDK4/6 inhibitors, fulvestrant and pertuzumab) for breast most cancers.

    Other developments

    Infectious illnesses – New medications stated include things like cefiderocol, a ‘Reserve’ group antibiotic productive against multi-drug resistant bacteria, echinocandin antifungals for severe fungal bacterial infections and monoclonal antibodies for rabies avoidance – the very first monoclonal antibodies in opposition to an infectious illness to be provided on the Design Lists. The updated lists also see new formulations of medicines for prevalent bacterial bacterial infections, hepatitis C, HIV and tuberculosis, to much better satisfy dosing and administration requires of the two children and grown ups. An supplemental 81 antibiotics had been categorized as Entry, Look at or Reserve beneath the Conscious framework, to aid antimicrobial stewardship and surveillance of antibiotic use worldwide.

    Smoking cigarettes cessation – Two non-nicotine-based medications – bupropion and varenicline – join nicotine-substitute treatment on the Design Listing, offering choice treatment solutions for folks who want to cease smoking. Listing aims to support the race to attain WHO’s ‘ Commit to Quit’ campaign purpose that would see 100 million men and women globally quitting smoking more than the coming year.

    Observe to Editors

    The assembly of the 23rd Professional Committee on the Collection and Use of Essential Medications was held almost from 21 June to 2 July. The Qualified Committee considered 88 purposes for medications to be included to the 21st WHO Product List of Critical Medications (EML) and the 7th WHO Product List of Important Medicines for Kids (EMLc). WHO technical departments have been associated and consulted with regard to applications relating to their sickness areas.

    The up to date Critical Medications Lists include things like 20 new medications for older people and 17 for youngsters and specify new uses for 28 already-outlined medicines. The improvements advised by the Pro Committee deliver the variety of medications deemed crucial to handle critical general public wellness desires to 479 on the EML and 350 on the EMLc. Whilst these numbers may look superior, they are only a smaller proportion of the total selection of medicines out there on the current market.

    Governments and establishments all-around the environment proceed to use the WHO Product Lists to guideline the progress of their personal important medications lists, because they know that each and every medicine stated has been vetted for efficacy and protection and delivers price for cash for the health results they create.

    The Product Lists are up to date each individual two many years by an Qualified Committee, manufactured up of identified professionals from academia, investigate and the medical and pharmaceutical professions. This calendar year, the Committee underscored the urgent require to choose action to boost equitable and cost-effective entry to crucial medications by the list and complementary steps these kinds of as voluntary licensing mechanisms, pooled procurement, and price tag negotiation.

  • Guidelines address considerations for topical therapy, alternative medicine in psoriasis

    Guidelines address considerations for topical therapy, alternative medicine in psoriasis

    September 27, 2021

    8 min read


    Disclosures:
    Armstrong reports she is a research investigator and scientific advisor to AbbVie, Bristol Myers Squibb, Boehringer Ingelheim, Celgene, Dermavant, Dermira, Galderma, Genentech, GlaxoSmithKline, Janssen, Kyowa Hakko Kirin, Leo, Lilly, Menlo, Merck, Modernizing Medicine, Novartis, Ortho Dermatologics, Pfizer, Regeneron, Sanofi and Modmed.


    We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected].

    Although multiple therapies, including systemic and biologic treatments, are effective in treating psoriasis, topical agents are an important component of psoriasis management, according to April W. Armstrong, MD.

    “Topical therapy has always been a keystone of therapy for patients with more limited psoriasis,” Armstrong, professor of dermatology and associate dean at Keck School of Medicine at USC, told Healio.

    April Armstrong, MD

    April W. Armstrong

    To address the significant advances in research made in topical therapy, the American Academy of Dermatology and the National Psoriasis Foundation released joint guidelines on the use of these agents in 2020. In addition, the guideline authors recognized the growing popularity of alternative medicine and sought to discuss its role in psoriasis management.

    In an interview with Healio, Armstrong, who helped author the guidelines, discussed some of the key recommendations regarding use of topical agents and alternative medicine as well as which tools may be most useful for gauging psoriasis disease severity.

    Healio: What prompted drafting the guidelines?

    Armstrong: First, topical agents have always played a role for patients with more limited psoriasis, so drafting and updating of the previous guidance on topical therapy was necessary to really reflect development in this exciting area.

    Second, there have also been several different developments in terms of alternative therapies or approaches to treating psoriasis. Consequently, the guidelines committee felt it was necessary to address alternative medicine to better inform our clinicians, who will likely be asked questions about these treatments, as well as benefit the community in general.

    Finally, the third part of the guidelines focuses on different psoriasis disease severity measures. Again, there has been tremendous development in this area, so we thought it was important to review these measurements and discuss their relevance in the clinical setting as well as the trial setting. This is important to help us monitor our patients’ psoriasis journey, but we also hope it will be informative for clinical trials as we evaluate different therapies.

    Healio: What are the most important recommendations with respect to topical therapies?

    Armstrong: We covered a number of different areas in our section on topical therapies. All are significant, but I will highlight two that are particularly important.

    First, we emphasize that topical steroids remain an effective and safe therapy for many patients with mild to moderate psoriasis. This is important because our patients often come across information saying that we still need more research concerning the benefits and side effects of topical steroids. After evaluating rigorous literature, the committee believes topical steroids still play an important and major role in management of limited psoriasis, and when used appropriately under the direction of dermatologists, they can still be quite effective.

    Second, we introduced the concept of proactive management, which arises from the understanding that psoriasis is a chronic disease that tends to occur and recur in the same areas for a person. This strategy involves treating psoriasis plaque to clear or almost clear during a flare and then applying a topical non-corticosteroid, such as a vitamin D analog or calcineurin inhibitor, to the area where the patient often experiences flare. However, instead of applying the treatment every day, the patient would do so maybe twice a week. This approach can reduce the number of flares as well as reduce the amount of medication that a patient is likely to use in the long term, so it is important that both clinicians and patients be aware of this strategy.

    I would also like to mention some “oldies but goodies” in terms of treatment. For instance, long-term studies have shown that topical vitamin D analogs are still very safe and can typically be used in larger quantities — potentially up to 100 g per week — in adults. We also specifically reemphasized that calcineurin inhibitors, such as tacrolimus or pimecrolimus, also remain safe when used topically. Back in 2005, the FDA added a boxed warning to calcineurin inhibitors regarding the risk for lymphoproliferative disorder. However, this was related to systemic exposure in animals, and, to date, there is no signal or safety concern with the topical use of calcineurin inhibitors for psoriasis.

    Finally, the guidelines address the use of combination topical therapy, which typically combines a topical steroid with a non-steroid agent, such as a topical vitamin D analog or a topical keratolyic agent. The advantage of many of these topical combination therapies is that the effects are quite synergistic, meaning they are generally more effective than either ingredient alone. Additionally, they often only require once daily dosing, so adherence is usually good among patients.

    Healio: What do the guidelines say regarding the use of topical therapies in combination with biologic or systemic therapies?

    Armstrong: Topical therapies make a good adjunct to biologic therapies or oral systemic therapies. For instance, a patient may be on a primary systemic agent — be it a biologic or oral systemic therapeutic agent — and may not achieve clearance to the degree that they would like. This would be a great opportunity to add a topical therapy to help reduce psoriasis severity in the hard-to-treat areas, such as the lower extremities. Often, we do not have the luxury of being able to switch a patient to another biologic due to their insurance or other barriers to access, in addition to the fact that they are reaping significant benefit from their current biologic. Therefore, the strategy here is to intensify topical treatment in those localized areas so that the patient can achieve clear or almost clear skin and be able to enjoy their life without feeling uncomfortable about their skin. This type of combination therapy is a good option, especially when the patient is achieving relatively good control of their psoriasis with the primary systemic agent.

    Healio: What would you say are the most important recommendations regarding alternative medicine?

    Armstrong: We covered several different topics in our section on alternative medicine and I encourage readers to review all of them. However, I will highlight a few that I believe are interesting.

    One area that we covered in the guidelines is traditional Chinese medicine. Several studies have shown that traditional Chinese medicine yields some benefit in psoriasis, but most of these studies were not standardized in terms of measurements or methodology, which made it difficult to synthesize the data. In addition, traditional Chinese medicine is often an umbrella term used to describe various types of therapies, so we need more data and probably specialists in herbology to weigh in while we evaluate some of those data the next time around.

    We also looked at a few other agents. Aloe vera and St. John’s wort, for example, have both shown some efficacy in patients with mild psoriasis. Again, though, we don’t have large studies with alternative medicines, and it would be a luxury to even have controlled studies, so although we recognize there may be some benefit to using these treatments in some patients, by and large, alternative medicine should really be considered as an adjunct to FDA-approved therapies. The reason for this is that the evidence for FDA-approved therapies is very robust while the level of evidence that we have for alternative medicine is just not there yet.

    Also, it’s imperative for our patients to recognize that alternative medicine is not without risks. The guidelines contain a section in which we discuss not only the potential benefits, but the risks associated with using these alternative therapies. This is very important to take into consideration as patients may often be unaware of some of the risks of alternative medicine because they perceive them to be “natural.” However, one should always be aware of the potential risks, especially of anything that is taken in larger quantities.

    In addition, we reviewed the role of diet as well as different supplements for psoriasis management. At the current time, the conversation around omega-3 oil remains controversial. There is evidence both for and against its use, meaning that the evidence does not support its beneficial effects in psoriasis. Evaluating the data here can be difficult because a lot of studies use different doses and different types of omega-3 oil that is refined in different ways, so we currently do not support the use of omega-3 oil as a monotherapy for psoriasis. Again, if patients want to add it on to their regular medical therapy for psoriasis to see if they may benefit, they can, but there are concerns about mercury toxicity and other risks depending on the way in which the fish oil is extracted.

    Oral vitamin D supplementation is also quite interesting. We know topical vitamin D supplementation, when formulated in the right fashion, is effective in treating psoriasis. However, the doses of oral vitamin D supplementation that were studied for psoriasis have not uniformly shown a significant benefit. Therefore, we again would not recommend oral vitamin D as a full treatment for psoriasis. Certainly, there are other health benefits to vitamin D supplementation, but when we’re looking at oral vitamin D for the treatment of psoriasis, we should inform our patients that the expectations should be a little bit muted.

    The last thing that I’ll highlight is the gluten-free diet because we get a lot of questions about this one from our patients. Based on our current understanding, the evidence does not support the independent significant benefit of a gluten-free diet for patients with psoriasis who have no history of celiac disease. However, if a patient has psoriasis as well as confirmed celiac disease, a gluten-free diet would be helpful. In those patients — who are actually few and far between — there is likely a much stronger connection between psoriasis and a gluten-free diet than in the majority of patients for whom that particular connection might be a bit more tenuous.

    Healio: How do the guidelines recommend that physicians assess disease severity?

    Armstrong: For psoriasis disease severity, we highlighted several different instruments in the guidelines, but we emphasize that there are three kinds of elements of defining psoriasis: what it looks like on the skin, which we as clinicians can observe; the symptoms, such as itching, burning and stinging; and how psoriasis impacts quality of life, including the effects on a patient’s work or personal relationships. It is important to take all three of those components into consideration.

    So, when we’re looking for signs of psoriasis, body surface area (BSA) is still one of the most useful measures for disease severity. Now, obviously, it is not all-encompassing and has its limitations, but it is very easy to use. When we think about 1{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} of BSA essentially being the area of the patient’s handprint, it is easier to explain to our patients and easy to assess in the clinic. Therefore, the guidelines reiterate the utility of BSA in the clinical context. In addition to that, we have the Physician Global Assessment where we rank the disease severity from clear to severe using a five-point scale, which is also easy to use and is helpful in terms of clinical utility.

    There are other measures, including the Psoriasis Area and Severity Index (PASI), which is used ubiquitously in clinical trials. However, although it’s very sensitive and responsive to change, it is not that easy to do clinically. Therefore, in the guidelines, we recognize that the utility of instruments such as PASI is most evident in clinical trial settings and perhaps less so in clinical settings unless a clinician is asked to use it to access to a medication, for example.

    Healio: Did the guideline authors identify areas that necessitate further research?

    Armstrong: Yes. We determined that we will need more evidence in all three areas that we discussed.

    In terms of FDA-approved topical therapies, the focus will be on non-steroidal topical agents that can be helpful in treating our patients with psoriasis. Additionally, the long-term use of topical agents is an area of interest as well.

    Regarding alternative medicine, it’s still a little bit of a ‘Wild West.’ We would love to have more research into the various agents out there to understand more precisely their efficacy and safety profiles so that we can inform our patients appropriately.

    Finally, in the area of psoriasis disease severity measurements, our field has come a long way in understanding disease burden and how to measure it. For example, last year, the International Psoriasis Council put out an article looking at psoriasis disease severity based on two categories: patients who are candidates for topical therapies and patients who are candidates for systemic therapy. So, there are a number of different movements trying to address some of our gaps in knowledge and more comprehensively capture the disease burden experienced by our psoriasis patients.

    Reference:

    Elmets CA, et al. J Am Acad Dermatol. 2020;doi:10.1016/j.jaad.2020.07.087.

    For more information:

    To follow April W. Armstrong, MD, on social media, follow @aprilarmstrongmd on Instagram or subscribe to her YouTube channel.